BEAM icon

Beam Therapeutics
BEAM

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$47
64% upside
High target

5 analyst ratings

positive
2  neutral
40%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Luca Issi
25 Feb ‘26 4 days ago
Wedbush
Wedbush
David Nierengarten
0% 1-yr BEAM win rate
25 Feb ‘26 4 days ago
Canaccord Genuity
Canaccord Genuity
Whitney Ijem
100% 1-yr BEAM win rate
20 Feb ‘26 9 days ago
Bernstein
Bernstein
William Pickering
0% 1-yr BEAM win rate
21 Jan ‘26 1 month ago
UBS
UBS
Michael Yee
7 Jan ‘26 1 month ago